Skip to content

Online or Face-to-face Treatment for Insomnia?

Online or Face-to-face Treatment for Insomnia? A Wait-list Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01955850
Enrollment
90
Registered
2013-10-08
Start date
2013-10-31
Completion date
2014-12-31
Last updated
2014-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Brief summary

The object of this study is to compare internet-delivered treatment for insomnia to face-to-face treatment and a waiting-list. In this study participants are randomized to: 1) online cognitive-behavioral intervention; 2) face-to-face cognitive behavioral intervention; 3) waiting-list. Both the online and face-to-face interventions consist of: diary; psycho-education; relaxation exercises; stimulus control/sleep hygiene; sleep restriction; challenging the misconceptions about sleep; and paradoxical exercise. Adult persons with insomnia will be invited via a popular scientific website to fill out online questionnaires. Participants fill out questionnaires and a dairy at baseline post-test, 3-month follow-up, and 6-month follow-up. Participants on the waiting-list receive online treatment after the first post-test. The investigators expect that the online-delivered treatment and the face-to-face treatment are equally effective.

Interventions

Cognitive behavioral treatment for insomnia, consisting of: psycho-education, sleep hygiene, stimulus control, sleep restriction, cognitive therapy.

Sponsors

Slaapmakend
CollaboratorUNKNOWN
VU University of Amsterdam
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Insomnia disorder according to DSM-5 * Sleep onset latency/wake after sleep onset \> 30 minutes , three times or more a week * Insomnia three months or longer * Access to internet * Possibility to travel to one of the treatment sites

Exclusion criteria

* Earlier cognitive behavioral treatment for insomnia * Start other psychological treatment in the last 6 months * Doing shift work * Major depression disorder * Pregnancy or breast feeding * Schizophrenia or psychosis * Suicidal plans * Sleep apnea * drugs or alcohol abuse

Design outcomes

Primary

MeasureTime frameDescription
Sleep continuity (consisting of sleep latency, time awake after sleep onset, total sleep time)Change from baseline to post-test, 3-months, and 6-months follow-upFor sleep continuity a 7-day sleep diary is used based on the consensus sleep diary.
Insomnia Severity IndexChange from baseline to post-test, 3-months, and 6-months follow-up

Secondary

MeasureTime frame
Sleep related worry measured with the Anxiety and Pre-occupation about Sleep ScaleChange from baseline to post-test, 3-months, and 6-months follow-up
Sleep related arousal measured with the Pre-arousal sleep scaleChange from baseline to post-test, 3-months, and 6-months follow-up
Depression measured with the CES-DChange from baseline to post-test, 3-months, and 6-months follow-up
Sleep medication usage per day measured with the sleep diaryChange from baseline to post-test, 3-months, and 6-months follow-up
Sleep related cognitions measured with the Dysfunctional Beliefs and Attitudes about sleep scale (DBAS)Change from baseline to post-test, 3-months, and 6-months follow-up
Anxiety (HADS-A)Change from baseline to post-test, 3-months, and 6-months follow-up

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026